This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Chest Computed Tomography (CT) Screening Study With Antibody Testing

This study has been withdrawn prior to enrollment.
(Due to lack of funding)
Information provided by:
Mayo Clinic Identifier:
First received: September 15, 2010
Last updated: June 20, 2012
Last verified: June 2012
The purpose of this study is to assess the value of EarlyCDT-Lung test and CT scan both in lung cancer detection and potential health economic outcomes.

Lung Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Different Strategies Using Autoantibodies and/or CT in the Detection of Lung Cancer

Resource links provided by NLM:

Further study details as provided by Mayo Clinic:

Enrollment: 0
Study Start Date: September 2011
Study Completion Date: September 2011
Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)
Detailed Description:
EarlyCDT-Lung test and CT scan both for lung cancer detection and potential economic outcomes.

Ages Eligible for Study:   50 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Current or Former Smokers with >20 pack year history and or family history of lung cancer. Ages 50-75 years old
  • Persons 50-75
  • Asymptomatic for lung cancer
  • Current or former (stopped smoking less than 10 years ago) cigarette smokers
  • History of cigarette smoking of at least 20 pack years
  • History of cigarette smoking with a family history of lung cancer which gives an individual a personal risk similar to a smoking history of 20 pk/years (i.e. 1% at 5 years).
  • Mentally competent individuals to sign an informed consent.
  • Healthy enough to undergo pulmonary resection or stereotactic body radiotherapy.
  • A fully informed signed consent form must have been obtained.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01203579

United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Principal Investigator: David Midthun, MD Mayo Clinic
  More Information

Responsible Party: David Midthun, MD, Mayo Clinic Identifier: NCT01203579     History of Changes
Other Study ID Numbers: 10-003048
Study First Received: September 15, 2010
Last Updated: June 20, 2012

Keywords provided by Mayo Clinic:
CDT-Lung,CT scan,lung cancer detection

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases processed this record on August 23, 2017